ObsEva SA, en liquidation is a Switzerland-based company which provides services in the fields of research, development, manufacture, registration, promotion and marketing of biotechnical and pharmaceutical products.

Employees

Sector

Biotechnology & Medical Research

More about the company

Market Cap	4.1M 3.58M 3.31M 3.1M 5.8M 387M 5.85M 39.27M 15.21M 190M 15.39M 15.06M 661M	P/E 2021	-2.57x	P/E 2022	-0.45x
Enterprise Value	-1.3M -1.13M -1.04M -979K -1.83M -122M -1.85M -12.41M -4.81M -60.16M -4.86M -4.76M -209M	EV / Sales 2021	-	EV / Sales 2022	0.65x
Free-Float	70.16%	Yield 2021 *	-	Yield 2022	-

23-04-20	ObsEva to Suspend Reporting With SEC Following Delisting From Nasdaq	MT
23-04-20	ObsEva to Change Central Securities Depositary to SIX SIS; Shares Up 9%	MT
23-04-11	Insider Buy: Obseva	MT
23-04-05	ObsEva SA announced that it has received CHF 0.344 million in funding	CI
23-03-31	ObsEva SA Reports Earnings Results for the Full Year Ended December 31, 2022	CI
23-03-30	ObsEva SA Auditor Raises 'Going Concern' Doubt	CI
23-03-22	ObsEva SA(OTCPK:OBSV.F) dropped from NASDAQ Composite Index	CI
23-03-15	ObsEva to Delist from Nasdaq, Deregister from US SEC	MT
23-03-13	ObsEva Names New CEO From May, Appoints Interim Chairman	MT
23-03-13	ObsEva Names New Interim Chairman, CEO as Reorganization Continues	MT
23-03-13	ObsEva SA Announces CEO Changes, Effective on or About May 1, 2023	CI
23-03-13	ObsEva SA Announces Executive Changes	CI
23-03-03	Top Premarket Gainers	MT

22-08-30	HC Wainwright Downgrades ObsEva to Neutral from Buy	MT
22-08-01	Canaccord Genuity Downgrades ObsEva to Hold From Buy, Adjusts Price Target to $1 From $12	MT
22-07-29	Cantor Fitzgerald Cuts ObsEva to Neutral From Overweight, Price Target to $1 From $6	MT
22-06-03	Cantor Fitzgerald Starts ObsEva at Overweight With $6 Price Target	MT
22-04-26	Canaccord Genuity Starts ObsEva at Buy With $12 Price Target	MT

23-04-20	ObsEva Announces Change of Central Securities Depositary	GL
23-04-20	ObsEva Announces Change of Central Securities Depositary	GL
23-03-31	ObsEva Files Year End 2022 Financial Statements	GL
23-03-22	OBSEVA SA : Other Events (form 8-K)	AQ
23-03-15	ObsEva : Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange - Form 8-K	PU

23-04-20	Obseva-Aktien erhalten im Zuge von Nasdaq-Dekotierung neue ISIN-Nummer
23-04-06	Bourse Zurich: le SMI maintient ses gains à l'approche de la mi-journée
23-04-06	Bourse Zurich: ouverture en hausse avant le long week-end pascal
23-03-31	Obseva bleibt 2022 tief in den roten Zahlen
23-03-31	Obseva reste profondément en rouge en 2022, doutes sur la suite

ObsEva SA Stock Swiss Exchange

Stocks

OBSN

CH1260041939

Biotechnology & Medical Research

Valuation: ObsEva SA

Latest news : ObsEva SA

Analysts' recommendations: ObsEva SA

Press Releases: ObsEva SA

News in other languages: ObsEva SA

Quotes and Performance

Bio Therapeutic Drugs

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
OBSEVA SA	-76.92%	-86.36%	-	-	11.72K
ARGENX SE	+1.44%	-1.25%	+63.52%	+114.88%	55.19B
WUXI APPTEC CO., LTD.	+4.60%	+3.02%	+58.20%	+47.16%	45.75B
BIONTECH SE	-1.44%	+0.39%	-12.94%	-19.24%	22.98B
INSMED INCORPORATED	-2.69%	-2.10%	-3.68%	+379.00%	20.76B
WUXI BIOLOGICS (CAYMAN) INC.	+3.22%	-0.84%	+27.88%	-34.00%	16.26B
GENMAB A/S	+0.58%	+1.08%	+16.73%	-38.06%	15.42B
EXELIXIS, INC.	-1.01%	-2.30%	+27.42%	+171.92%	13.05B
PHARMAESSENTIA CORPORATION	+4.95%	+11.70%	+123.63%	+252.19%	12.45B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+3.07%	+0.14%	+29.37%	-	12.37B
Average	-6.42%	+2.23%	+36.68%	+109.23%	23.8B
Weighted average by Cap.	+1.63%	+1.48%	+40.92%	+99.91%

	2021	2022
Net sales	-	19.64M 17.12M 15.84M 14.84M 27.79M 1.85B 28.01M 188M 72.85M 912M 73.7M 72.12M 3.17B
Net income	-58.38M -50.9M -47.08M -44.12M -82.62M -5.51B -83.26M -559M -217M -2.71B -219M -214M -9.41B	-29.88M -26.05M -24.09M -22.58M -42.28M -2.82B -42.62M -286M -111M -1.39B -112M -110M -4.82B
Net Debt	-28.08M -24.48M -22.64M -21.22M -39.73M -2.65B -40.04M -269M -104M -1.3B -105M -103M -4.53B	-5.4M -4.71M -4.35M -4.08M -7.64M -509M -7.7M -51.67M -20.02M -251M -20.26M -19.82M -870M